Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
(AMEX: IVBIY) Delayed: 54.29 --0 (-0%)
Previous Close $54.29    52 Week High $ 
Open $54.29    52 Week Low $ 
Day High $54.29    P/E N/A 
Day Low $54.29    EPS $ 
Volume 10,552       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.21 -0.01 (0.82%)
Previous Close $1.22    52 Week High $3.85 
Open $1.20    52 Week Low $1.25 
Day High $1.22    P/E N/A 
Day Low $1.19    EPS $-0.28 
Volume 362,984